To investigate whether CAR19‐IL24‐iNK cells still strengthened antitumor activity in vivo, the tumor growth was monitored by measuring the fluorescence signal of Nalm‐6 (Luc1) and proliferation of iNK cells labeled with DiR by bioluminescence imaging (BLI) over time. The gene discussed is IL24; the disease is neoplasm.